VAR2-armed CAR T-cells as an immunotherapeutic strategy for bladder cancer

VAR2-armed CAR T-cells as an immunotherapeutic strategy for bladder cancer

Bibliographic Details
Main Authors:	H.Z. Oo, N. Khazamipour, G. Ardekani, M. Roberts, N. Al Nakouzi, T. Gustavsson, L. Fazli, A. Salanti, P. Black, M. Daugaard
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320326100

Similar Items

Bladder cancer : an examination of immunotherapeutic strategies
by: Pettit, Stephen James
Published: (1999)

Immunoprofiling of Bladder Cancer: Setting the Basis for Novel Immunotherapeutic Strategies
by: Nicole Ferreira Viveiros
Published: (2021)

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
by: Shabnum Patel, et al.
Published: (2019-04-01)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
by: Liang-Hao Zhang, et al.
Published: (2021-04-01)

Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors
by: Nastaran Khazamipour, et al.
Published: (2020-03-01)

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
by: Olivier Adotevi, et al.
Published: (2021-03-01)

Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies
by: Rossella Sartorius, et al.
Published: (2019-09-01)

Immunotherapeutic Advances for NSCLC
by: Massafra M, et al.
Published: (2021-10-01)

Immunotherapeutic Challenges for Pediatric Cancers
by: Brian Hutzen, et al.
Published: (2019-12-01)

Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice
by: Estela Noguera-Ortega, et al.
Published: (2018-10-01)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
by: Lianghao Zhang, et al.
Published: (2021-01-01)

Editorial: Complement and Immunotherapeutics
by: Marcin Okrój, et al.
Published: (2021-02-01)

Immunotherapeutic advancements for glioblastoma
by: Leonel eAmpie, et al.
Published: (2015-01-01)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
by: Wen Jiang, et al.
Published: (2020-04-01)

Novel Immunotherapeutic Approach in Gastric Cancer
by: Gulubova M., et al.
Published: (2020-07-01)

Immunotherapeutic modulation of intraperitoneal adhesions by Asparagus racemosus.
by: Rege N, et al.
Published: (1989-10-01)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
by: Rui Cao, et al.
Published: (2020-06-01)

IMMUNOTHERAPEUTIC METHOD FOR TREATMENT OF KAPOSI’S SARCOMA
by: M. G. Kartashova, et al.
Published: (2016-02-01)

Immunotherapeutic Applications of NK Cells
by: Carter T. Davis, et al.
Published: (2015-05-01)

Immunotherapeutic Intervention against Sarcomas
by: Paolo Pedrazzoli, Simona Secondino, Vittorio Perfetti, Patrizia Comoli, Daniela Montagna
Published: (2011-01-01)

Immunotherapeutic potential of extracellular vesicles
by: Bin eZhang, et al.
Published: (2014-10-01)

Immunotherapeutic Targeting in Autoimmune Diseases
by: Nona Janikashvili, et al.
Published: (2016-01-01)

Peptide-Based Immunotherapeutics and Vaccines
by: Pedro A. Reche, et al.
Published: (2014-01-01)

Translation of peptidoglycan metabolites into immunotherapeutics
by: Matthew E Griffin, et al.
Published: (2019-01-01)

New Immunotherapeutic Approaches for Glioblastoma
by: Gustavo Ignacio Vázquez Cervantes, et al.
Published: (2021-01-01)

Immunotherapeutic approaches in the treatment of melanoma
by: Donnelly, Oliver
Published: (2012)

Recent advancements in cancer immunotherapeutics
by: Kim, Susie
Published: (2016)

Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis
by: Leandro C. D. Breda, et al.
Published: (2021-12-01)

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
by: Michael V. Ortiz, et al.
Published: (2019-02-01)

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
by: Daniel E. Meyers, et al.
Published: (2017-06-01)

Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
by: Priyanka Hirani, et al.
Published: (2021-08-01)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
by: Amedeo Amedei, et al.
Published: (2011-01-01)

Immunotherapeutic and Targeted Approaches in Multiple Myeloma
by: Nadeem O, et al.
Published: (2020-10-01)

Experiences and expectations for glioma immunotherapeutic approaches
by: Ryuya eYamanaka, et al.
Published: (2014-12-01)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
by: Stephen eThorne
Published: (2014-06-01)

Current Immunotherapeutic Approaches in Pancreatic Cancer
by: Shigeo Koido, et al.
Published: (2011-01-01)

Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
by: Joel F. Aldrich, et al.
Published: (2010-01-01)

Peptide-Based Immunotherapeutics and Vaccines 2015
by: Pedro Reche, et al.
Published: (2015-01-01)

Phytochemicals Approach for Developing Cancer Immunotherapeutics
by: Shu-Yi Yin, et al.
Published: (2017-06-01)

Immunotherapeutic Strategies for Alzheimer's Disease Treatment
by: Beka Solomon
Published: (2009-01-01)